TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
ADD Accelerated Drug Development AB
Closing information (x1000 EUR)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
52
|
44 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
0
|
0 | |
| EBITDA |
0
|
0 | |
| Total assets |
421
|
389 | |
| Current assets |
189
|
145 | |
| Current liabilities |
363
|
339 | |
| Equity capital |
48
|
51 | |
| - share capital |
47
|
49 | |
| Employees (average) |
0
|
0
|
1 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
11.4%
|
13.1% | |
| Turnover per employee | 44 | ||
| Profit as a percentage of turnover |
0%
|
0% | |
| Return on assets (ROA) |
0%
|
0% | |
| Current ratio |
52.1%
|
42.8% | |
| Return on equity (ROE) |
0%
|
0% | |
| Change turnover |
10
|
13 | |
| Change turnover % |
14%
|
24%
|
43% |
| Chg. No. of employees |
0
|
-1
|
0 |
| Chg. No. of employees % |
-100%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.